Cardiac enzyme elevations after percutaneous coronary intervention: Myonecrosis, the coronary microcirculation and mortality

被引：11
|
作者：
Harrington, RA [1 ]
机构：
[1] Duke Univ, Med Ctr, Duke Clin Res Inst, Dept Med,Div Cardiol, Durham, NC 27705 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2000年 / 35卷 / 05期
关键词：
D O I：
10.1016/S0735-1097(00)00524-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1142 / 1144
页数：3
相关论文
共 50 条
  • [41] Different mechanisms for minor myocardial damage versus myonecrosis after percutaneous coronary intervention.
    Gomez-Hospital, J
    Soteres, EI
    Politi, JV
    Castro, MJ
    Fillat, AC
    Maristany, J
    Pascual, M
    Sureda, FJ
    Oliveras, EE
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (6A): : 171E - 171E
  • [42] Relation between coronary atherosclerotic plaque burden and cardiac enzyme elevation following percutaneous coronary intervention
    Kanaparti, PK
    Brown, DL
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (06): : 619 - 622
  • [43] CORONARY THROMBECTOMY AFTER UNSUCCESSFUL PERCUTANEOUS CORONARY INTERVENTION
    Guler, A.
    Tavlasoglu, M.
    Kurkluoglu, M.
    Arslan, Z.
    Sahin, M. A.
    Gunay, C.
    Yesil, F. G.
    Cingoz, F.
    Arslan, M.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 163 : S63 - S63
  • [44] Prognostically relevant cardiac troponin elevations with percutaneous coronary interventions
    Bulluck, Heerajnarain
    Thygesen, Kristian
    Hausenloy, Derek J.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 (09) : 921 - 922
  • [45] Cardiac enzyme elevation after successful percutaneous coronary intervention is not an independent predictor of adverse outcomes - Response
    Bhatt, DL
    Topol, EJ
    [J]. CIRCULATION, 2005, 112 (06) : 922 - 922
  • [46] PERCUTANEOUS CORONARY INTERVENTION FOR POOR CORONARY MICROCIRCULATION REPERFUSION OF PATIENTS WITH STABLE ANGINA PECTORIS
    Li, J. S.
    Zhao, X. J.
    Ma, B. X.
    Wang, Z.
    [J]. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2016, 30 (03): : 733 - 741
  • [47] Estrogen replacement therapy and morbidity and mortality after percutaneous coronary intervention
    Gruberg, L
    Silverman, A
    PInnow, EE
    Suddath, WO
    Satler, LF
    Laird, JR
    Pichard, AD
    Kent, KM
    Lindsay, J
    Waksman, R
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 50A - 50A
  • [48] Renal failure after percutaneous coronary intervention is associated with high mortality
    Gupta, R
    Gurm, HS
    Bhatt, DL
    Chew, DP
    Ellis, SG
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2005, 64 (04) : 442 - 448
  • [49] Predicting 3-Year Mortality After Percutaneous Coronary Intervention
    Iqbal, Javaid
    Vergouwe, Yvonne
    Bourantas, Christos V.
    Klaveren, David V.
    Zhang, Yao-Jun
    Campos, Carlos M.
    Garcia-Garcia, Hector M.
    Morel, Marie-Angele
    Valgimigli, Marco
    Windecker, Stephan
    Steyerberg, Ewout W.
    Serruys, Patrick W.
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (05) : 464 - 470
  • [50] Baseline hemoglobin is a novel predictor of mortality after percutaneous coronary intervention
    Kini, AS
    Lee, P
    Mitre, CA
    Sharma, SK
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 10A - 10A
12345